Effects of Chenpi Jiaosu on serum metabolites and intestinal microflora in a dyslipidemia population: a randomized controlled pilot trial
IntroductionDyslipidemia is a critical risk factor for atherosclerosis and cardiovascular/cerebrovascular events, necessitating effective long-term management. However, conventional lipid-lowering drugs such as statins and fibrates are limited by adverse effects, including hepatotoxicity and myopath...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2025-03-01
|
| シリーズ: | Frontiers in Endocrinology |
| 主題: | |
| オンライン･アクセス: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1552117/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|